News from Bayer
June 23, 2021
Not intended for U.S. and UK Media
Vericiguat approved in Japan to treat patients with chronic heart failure
June 21, 2021
Not intended for U.S. and UK Media
Bayer submits regulatory applications for oncology treatment combination of copanlisib and rituximab in the U.S. and EU
June 08, 2021
Bayer to advance two first-of-its-kind cell and gene therapies for Parkinson’s disease